Facio was founded by FSHD-affected families for the sole purpose of developing safe, effective and affordable therapies for all people with FSHD.
We developed an FSHD screening platform, discovered new opportunities to tackle the cause of FSHD, and showed proof of principle in a unique animal model. Now, we are paving the way to clinical trials.
We, people living with FSHD, are not condemned to waiting and hoping for a breakthrough to happen; we can make that breakthrough ourselves.
We can. That is our message.